Quagen Pharmaceuticals, LLC (DEA 1701)

Documents

Comments

Key Dates

Comment Period OpensApr 21, 2026

Comment Period ClosesMay 19, 2026

Type	Title	Posted	Comments	Status
Notice	2026-07559 FR Doc: 2026-07559	Apr 21, 2026	--